PLURISTEM THERA (NASDAQ:PSTI)
1.14
0.02 (1.72%)
| PLURISTEM THERA (NASDAQ:PSTI) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $1.16 | 52 Week High | $2.29 | ||
| Open | $1.16 | 52 Week Low | $0.30 | ||
| Day High | $1.16 | P/E | N/A | ||
| Day Low | $1.09 | EPS | $-0.48 | ||
| Volume | 72,735 | ||||
| More PSTI Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| GERN | 7 | STEM | 7 |
| ASTM | 6 | CYTX | 5 |
| WMT | 3 | GERN | 3 |
| ICTG | 3 | JPM | 2 |
| WFC | 2 | AVCT | 2 |
| SRDX | 2 | BAC | 2 |
Entities who have mentioned PSTI
- Unusual 11 Mid-Day Movers | View Related Stories »
- JPMorgan | View Related Stories »
- Barack Obama | View Related Stories »
- Dividend | View Related Stories »
- Stock Buyback | View Related Stories »
- Jefferies & Co | View Related Stories »
- Goldman Sachs | View Related Stories »
- Citi | View Related Stories »
- Morgan Stanley | View Related Stories »
- Banc of America | View Related Stories »
- Crude Oil | View Related Stories »
- UBS | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- Life, Style and Real Estate | View Related Stories »
- Buckingham Research | View Related Stories »
- Piper Jaffray | View Related Stories »
- Roth Capital | View Related Stories »
- Calyon Securities | View Related Stories »
- S3 | View Related Stories »
- RBC Capital | View Related Stories »
- D.A. Davidson | View Related Stories »
- Deutsche Bank | View Related Stories »
- Wachovia | View Related Stories »
- Bankruptcy | View Related Stories »
- Credit Suisse | View Related Stories »
StreetInsider.com Major News for PSTI
View All ReportsStreetInsider.com Reports on PSTI
- Pluristem Therapeutics (PSTI) Announces Safety and Efficacy Parameters for PLX-PAD Placenta Cell Therapy
- Unusual 11 Mid-Day Movers 10/06: FONR, ICTG, ACAD, AVCT Higher; MNKD, VRNMD, ARP, PPD Lower
- Morning Movers 10/06: FONR, ICTG, PEDH, AVCT, SRDX, NTRI Higher; VRNMD, MNKD, ARP, PSTI, EXTR, STJ Lower
- Pluristem Therapeutics (PSTI) Sells 2.7M Shares at $1.12, With Warrants to Boot
- Pluristem (PSTI) Provides Disclosure Pursuant to NASDAQ Marketplace Rule 5250
View All Press ReleasesCompany Press Releases on PSTI
- Pluristem Therapeutics Presents Three Month Follow-Up Data from First Patient to Receive Placental Derived PLX-PAD at Two Meetings in Germany and France
- Pluristem Therapeutics Announces Three Month Follow-Up Data from the First Patient to Receive PLX-PAD
- Pluristem Therapeutics Will Chair a Panel Presentation on Placenta-Derived Adult Stem Cells at the World Conference on Regenerative Medicine
- Pluristem Therapeutics Will Present at the New England-Israel Life Sciences Summit
- Pluristem Therapeutics to Raise $3.0 Million in Registered Direct Offering
StreetInsider Reports on PSTI by Category
Comments on recent PSTI articles
Comments on PSTI
No comments are currently available.
on Mar 2, 2009
at 06:16 PM RE: SCLL PSTI SEEMS TO GET CREDIT FOR WORK SCLL DOES, WHY? BECAUSE THEY ARE THE PARENT COMPANY?
Article: Pluristem Therapeutics (PSTI) Announces Clearance for "First-In-Human" Placenta-Derived Stem Cell Clinical Trial